2020
DOI: 10.5137/1019-5149.jtn.28138-19.2
|View full text |Cite
|
Sign up to set email alerts
|

D-serine and nmda receptor 1 expression in patients with intractable epilepsy

Abstract: AIM:To investigate the expression patterns of D-serine and N-methyl-D-aspartate (NMDA) receptor 1 in the temporal lobes of patients with intractable epilepsy. MATERIAL and METHODS:Cortical temporal lobe brain tissue samples were collected from 20 patients with intractable epilepsy and 6 patients with brain trauma. The expression patterns of D-serine and NMDA receptor 1 were detected by immunofluorescence staining and western blot analysis. RESULTS:A total of 20 patients (11 males, 9 females) were included in t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 25 publications
0
6
0
Order By: Relevance
“…A subsequent study in 2021 performed immunofluorescence staining and western blotting to identify the expression patters of D-serine and NMDA receptor 1 in patients with intractable epilepsy [ 58 ]. The level of D-serine was greater in the neurons and glial cells in patients afflicted with intractable epilepsy than in control participants [ 58 ].…”
Section: Serines and Epilepsymentioning
confidence: 99%
See 1 more Smart Citation
“…A subsequent study in 2021 performed immunofluorescence staining and western blotting to identify the expression patters of D-serine and NMDA receptor 1 in patients with intractable epilepsy [ 58 ]. The level of D-serine was greater in the neurons and glial cells in patients afflicted with intractable epilepsy than in control participants [ 58 ].…”
Section: Serines and Epilepsymentioning
confidence: 99%
“…A subsequent study in 2021 performed immunofluorescence staining and western blotting to identify the expression patters of D-serine and NMDA receptor 1 in patients with intractable epilepsy [ 58 ]. The level of D-serine was greater in the neurons and glial cells in patients afflicted with intractable epilepsy than in control participants [ 58 ]. The mean absorbance of NMDA receptor 1 was also higher in patients with intractable epilepsy when compared with control participants, indicating the possible implication of this pathway in the Epileptogenesis [ 58 ].…”
Section: Serines and Epilepsymentioning
confidence: 99%
“…D-serine and NMDAR were found to be significantly upregulated in patients with intractable epilepsy (Zhang et al, 2021). Therefore, the D-serine signal pathway may be a potential target for epilepsy therapy.…”
Section: D-serinementioning
confidence: 99%
“…The modulation of the GMS of the NMDAR is low, given the low saturation in vivo despite the high CSF concentrations of glycine [ 31 ]. D-serine serves as a major endogenous co-agonist of the NMDAR, and D-serine levels were recently found to be upregulated in intractable epilepsy [ 32 , 33 , 34 ]. It is possible that endogenous glycine does not fully stimulate NMDARs as suggested by the selective potentiation of the convulsant activity of NMDA by D-serine [ 35 ].…”
Section: Nmdar Complexmentioning
confidence: 99%
“…In human patients with symptomatic epilepsies, the regulation of the GluN2B subunit of the NMDAR complex via NRG1-ErbB4-Src signaling pathways was identified as a potential modulating target through the use of the immunoblotting technique [ 69 ]. In patients with intractable temporal lobe epilepsies, D-serine and NMDAR1 expressions were significantly increased [ 34 ]. These observations highlight the importance of neurochemical targeting, which can be further explored in the future to guide anti-NMDAR complex therapies.…”
Section: Nmdar Alterations and Their Role In Human Epilepsymentioning
confidence: 99%